AdaptHealth Corp vs Roundhill Innov-100 0DTE Covered Call Strat ETF — how do they compare? AdaptHealth Corp trades at $5.8 (market cap $753.09M), while Roundhill Innov-100 0DTE Covered Call Strat ETF trades at $29.58. The key difference: Roundhill Innov-100 0DTE Covered Call Strat ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | QDTE | |
|---|---|---|
Market Cap | $753.09M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $13.38 | $36.60 |
52-Week Low | $5.22 | $26.85 |
Enterprise Value | $2.77B | — |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.77, up 10.54% today but remains under significant pressure following recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal revenue growth but negative profitability margins. Recent news highlights multiple securities fraud investigations and a strategic shift through the sale of its diabetes unit to focus on sleep and respiratory care.
Despite 75% analyst buy ratings and an $11 consensus price target suggesting substantial upside, immediate risks are elevated. The company faces execution challenges with fixed-price contracts, ongoing legal scrutiny, and consecutive earnings misses. Investors must weigh the potential recovery against substantial operational and legal headwinds.
QDTE trades at $29.80, up 0.51% on the day, with a bearish technical signal from moving averages and oscillators showing neutral momentum. The fund faces scrutiny over its high distribution yield, which is reportedly funded by return of capital, leading to net asset value erosion. Recent news highlights underperformance in bull markets and concerns about the sustainability of its weekly payout strategy.
The outlook is cautious due to structural risks in the covered call strategy, with potential for continued NAV decline outweighing the attractive yield. Investors should weigh the income benefits against the risk of capital depletion, as analyst sentiment has turned negative with recent downgrades emphasizing the fund's vulnerability to market volatility.
Trailing returns across standard periods
Latest headlines on both assets
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →QDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the NASDAQ 100. It primarily holds a portfolio of U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the NASDAQ 100. This highly tactical strategy aims to maximize option premium capture by exploiting the rapid time decay of options expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on QDTE →